Differential regulation of TP73 isoforms by 1α,25-dihydroxyvitamin D3 and survivin in human colon and breast carcinomas

✍ Scribed by Raquel Díaz; José M. González-Sancho; Beatriz Soldevilla; Javier Silva; José M. García; Vanesa García; Cristina Peña; Mercedes Herrera; Irene Gómez; Félix Bonilla; Gemma Domínguez

• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 298 KB
• Volume: 49
• Category: Article
• ISSN: 1045-2257
• DOI: 10.1002/gcc.20821

✦ Synopsis

We evaluate whether 1,25(OH) 2 D 3 downregulates TP73 variants in colon and breast carcinomas, the role of survivin in this context, and the significance of this network in the clinic. Tumor cells were treated/untreated with 1,25(OH) 2 D 3 and transiently transfected with survivin. Levels of survivin and TP73 variants were evaluated by quantitative RT-PCR and Western blotting. In 75 colon and 60 breast cancer patients, the expressions of survivin and TP73 isoforms were determined. Tumor characteristics were examined in each patient. Survivin protein levels were also evaluated in a subgroup of patients and cell lines. Decrease in survivin and TAp73 transcripts and protein and DNp73 mRNA was detected after 1,25(OH) 2 D 3 treatment. Ectopic survivin expression led to an increase in the TAp73, DNp73, DEx2p73, and DEx2-3p73 transcripts. In cancer patients, direct correlations were observed between TP73 variants and survivin levels. 1,25(OH) 2 D 3 negatively regulate survivin and TP73 variants in colon and breast cancer cells. Positive regulation of TP73 isoforms by survivin may exist, which reinforces the possibility that the downregulation of TP73 forms by 1,25(OH) 2 D 3 is survivin-dependent.

V